Gelstat Corp GSAC
The SEC does not publish structured financial data (XBRL) for Gelstat Corp, so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 1-Z | Filing | May 11, 2026 | — |
| 1-U | Filing | Apr 30, 2026 | Mar 2, 2026 |
| 1-SA | Form 1-sa | Sep 29, 2025 | Jun 30, 2025 |
| 1-K | Filing | Apr 29, 2025 | Dec 31, 2024 |
| 1-SA | Semi annual report | Sep 26, 2024 | Jun 30, 2024 |
| 1-K | Filing | May 7, 2024 | Dec 31, 2023 |
| 1-U | Form 1-u | Nov 28, 2023 | Sep 30, 2023 |
| 1-SA | Semi annual report | Oct 12, 2023 | Jun 30, 2023 |
| 1-K | Filing | May 10, 2023 | Dec 31, 2022 |
| 1-U | Current report | Oct 7, 2022 | Oct 5, 2022 |
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GSAC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC CIK
- 890725
- Former names
- DEVELOPED TECHNOLOGY RESOURCE INC (until Jul 15, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.